Literature DB >> 9048634

Immunohistochemical analysis of androgen effects on androgen receptor expression in developing Leydig and Sertoli cells.

L X Shan1, C W Bardin, M P Hardy.   

Abstract

Leydig and Sertoli cells are both targets of androgen action in the testis. Androgen exerts contrasting effects on the two cell types partially inhibiting steroidogenesis in adult Leydig cell and stimulating adult Sertoli cell functions required to support spermatogenesis. The developmental changes in the messenger RNA (mRNA) levels of androgen receptor (AR) also differ between Leydig and Sertoli cells, with Leydig cell AR mRNA being highest on day 35 postpartum, whereas Sertoli cell AR mRNA levels are highest on day 90. The purpose of the present study was to determine if the concentrations of AR in Leydig and Sertoli cells are differentially regulated during development using quantitative immunostaining. AR protein levels were measured in rat testes after hormonal treatments at three developmental stages: on days 21, 35, and 90 postpartum. At each age, five groups of animals were treated for 4 days with: 1) vehicle; 2) LHRH antagonist (NalGlu, 0.3 mg/kg BW.day) to suppress endogenous levels of androgen that accompany inhibition of LH and FSH secretion; 3) NalGlu + LH (0.2 mg/kg BW.day); 4) NalGlu + testosterone (T, at 7.5 mg/kg BW.day); and 5) NalGlu + MENT (a potent synthetic androgen, 7 alpha-methyl-19-nortestosterone, 0.7 mg/kg BW.day). AR protein was visualized by immunohistochemistry and measured by computer-assisted image analysis in Leydig and Sertoli cells using frozen sections of tests. After NalGlu treatment, AR levels in Leydig cells declined sharply to 42% and 31% of vehicle control (P < 0.01) in the 21 and 35 days postpartum age groups, respectively, but in 90-day-old rats there was no change. AR levels were partially maintained by exogenous LH, and completely maintained by exogenous androgen treatments in Leydig cells from 21- and 35-day-old rats, whereas in Leydig cells from 90-day-old rats, AR levels were unaffected in all treatment groups. In contrast, after NalGlu treatment, the AR concentration in Sertoli cells from 90-day-old rats were reduced to 32% of control (P < 0.01). Moreover, in Sertoli cells from 90-day-old rats, AR levels were partially maintained by LH and completely maintained by androgens. A similar trend was observed on day 35. On day 21, however, AR levels in immature Sertoli cells were unaffected in all treatment groups. These results indicate that androgen maximally stimulates AR levels in immature Leydig cells but is without significant effect in adult Leydig cells. In contrast, AR levels in Sertoli cells are more sensitive to androgen regulation in adult compared with immature animals. These findings indicate that there are distinct mechanisms controlling AR concentrations in Leydig and Sertoli cells during the development of the testis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048634     DOI: 10.1210/endo.138.3.4973

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Lack of AR in LepRb Cells Disrupts Ambulatory Activity and Neuroendocrine Axes in a Sex-Specific Manner in Mice.

Authors:  Alexandra L Cara; Martin G Myers; Carol F Elias
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

2.  Effects of luteinizing hormone and androgen on the development of rat progenitor Leydig cells in vitro and in vivo.

Authors:  Jing-Jing Guo; Xue Ma; Claire Q F Wang; Yu-Fei Ge; Qing-Quan Lian; Dianne O Hardy; Yu-Fei Zhang; Qiang Dong; Yun-Fei Xu; Ren-Shan Ge
Journal:  Asian J Androl       Date:  2013-06-24       Impact factor: 3.285

3.  Infertility with defective spermatogenesis and steroidogenesis in male mice lacking androgen receptor in Leydig cells.

Authors:  Qingquan Xu; Hung-Yun Lin; Shauh-Der Yeh; I-Chen Yu; Ruey-Shen Wang; Yen-Ta Chen; Caixia Zhang; Saleh Altuwaijri; Lu-Min Chen; Kuang-Hsiang Chuang; Han-Sun Chiang; Shuyuan Yeh; Chawnshang Chang
Journal:  Endocrine       Date:  2007-10-23       Impact factor: 3.633

4.  Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells.

Authors:  Chawnshang Chang; Yen-Ta Chen; Shauh-Der Yeh; Qingquan Xu; Ruey-Sheng Wang; Florian Guillou; Henry Lardy; Shuyuan Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

5.  Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance.

Authors:  Hugo H Ortega; Natalia R Salvetti; Vasantha Padmanabhan
Journal:  Reproduction       Date:  2009-03-04       Impact factor: 3.906

6.  Molecular cloning, characterization, and gene expression of the androgen receptor in the large yellow croaker, Larimichthys crocea.

Authors:  Lulu Pu; Kunhuang Han; Fangjing Xie; Zhihua Zou; David Close; Ziping Zhang; Yilei Wang
Journal:  Fish Physiol Biochem       Date:  2012-08-04       Impact factor: 2.794

7.  Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells.

Authors:  Helen H N Yan; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  FASEB J       Date:  2008-01-11       Impact factor: 5.191

8.  Effects of adult onset mild calorie restriction on weight of reproductive organs, plasma parameters and gene expression in male mice.

Authors:  J S Rocha; M S Bonkowski; M M Masternak; L R França; A Bartke
Journal:  Anim Reprod       Date:  2012-01-01       Impact factor: 1.807

9.  Models of in vitro spermatogenesis.

Authors:  Damien Hunter; Ravinder Anand-Ivell; Sandra Danner; Richard Ivell
Journal:  Spermatogenesis       Date:  2012-01-01

10.  Androgen receptor expression in the testes and epididymides of prenatal and postnatal Sprague-Dawley rats.

Authors:  L You; M Sar
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.